Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fierro

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The American Surgeon|May 13, 2022
No Resuscitative Thoracotomy? When to Stop Chest Compressions After Prehospital Traumatic Cardiac ArrestNicole M Fierro, Navpreet K Dhillon, Felix A Yong, et al.
La Medicina Del Lavoro|September 22, 2009
[The contribution of the Italian scientific community to efficacy studies in Occupational Health (1990-2006)]S Mattioli, A Baldasseroni, Donatella Placidi, et al.
The Journal of Surgical Research|June 17, 2023
Inadequate Venous Thromboembolism Chemoprophylaxis Is Associated With Higher Venous Thromboembolism Rates Among Trauma Patients With EpiduralsNavpreet K Dhillon, Tobias Muniz, Nicole M Fierro, et al.
The American Surgeon|October 27, 2021
Early Propranolol Is Associated With Lower Risk of Venous Thromboembolism After Traumatic Brain InjuryNavpreet K Dhillon, Yassar M Hashim, Geena Conde, et al.
International Journal of Cancer|September 13, 2016
Lipoxin A<sub>4</sub> selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progressionR L Simões, N M De-Brito, H Cunha-Costa, et al.
The Journal of Pharmacy and Pharmacology|August 24, 1999
Anti-inflammatory profile of N-phenylpyrazole arylhydrazone derivatives in ratsC Barja-Fidalgo, I M Fierro, A C Brando Lima, et al.
British Journal of Pharmacology|January 15, 2008
ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factorP F T Cezar-de-Mello, A M Vieira, V Nascimento-Silva, et al.
Expert Opinion on Therapeutic Patents|August 31, 2016
Case study of patents related to captopril, Squibb's first blockbusterAdelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Jorge de Paula Costa Ávila, et al.
Journal of Leukocyte Biology|April 16, 1999
Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activityI M Fierro, V Nascimento-DaSilva, M A Arruda, et al.
The American Surgeon|May 13, 2022
Complications and Transfusions on Therapeutic Anticoagulation After TraumaAnaar E Siletz, Navpreet K Dhillon, Nicole M Fierro, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The American Surgeon|May 13, 2022
No Resuscitative Thoracotomy? When to Stop Chest Compressions After Prehospital Traumatic Cardiac ArrestNicole M Fierro, Navpreet K Dhillon, Felix A Yong, et al.
La Medicina Del Lavoro|September 22, 2009
[The contribution of the Italian scientific community to efficacy studies in Occupational Health (1990-2006)]S Mattioli, A Baldasseroni, Donatella Placidi, et al.
The Journal of Surgical Research|June 17, 2023
Inadequate Venous Thromboembolism Chemoprophylaxis Is Associated With Higher Venous Thromboembolism Rates Among Trauma Patients With EpiduralsNavpreet K Dhillon, Tobias Muniz, Nicole M Fierro, et al.
The American Surgeon|October 27, 2021
Early Propranolol Is Associated With Lower Risk of Venous Thromboembolism After Traumatic Brain InjuryNavpreet K Dhillon, Yassar M Hashim, Geena Conde, et al.
International Journal of Cancer|September 13, 2016
Lipoxin A<sub>4</sub> selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progressionR L Simões, N M De-Brito, H Cunha-Costa, et al.
The Journal of Pharmacy and Pharmacology|August 24, 1999
Anti-inflammatory profile of N-phenylpyrazole arylhydrazone derivatives in ratsC Barja-Fidalgo, I M Fierro, A C Brando Lima, et al.
British Journal of Pharmacology|January 15, 2008
ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factorP F T Cezar-de-Mello, A M Vieira, V Nascimento-Silva, et al.
Expert Opinion on Therapeutic Patents|August 31, 2016
Case study of patents related to captopril, Squibb's first blockbusterAdelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Jorge de Paula Costa Ávila, et al.
Journal of Leukocyte Biology|April 16, 1999
Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activityI M Fierro, V Nascimento-DaSilva, M A Arruda, et al.
The American Surgeon|May 13, 2022
Complications and Transfusions on Therapeutic Anticoagulation After TraumaAnaar E Siletz, Navpreet K Dhillon, Nicole M Fierro, et al.
Pageof 7